JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB275010

Human SCARB2 knockout MCF7 cell lysate

Be the first to review this product! Submit a review

|

(0 Publication)

SCARB2 KO cell lysate available now. KO validated by Next Generation Sequencing, Western blot. Free of charge wild type control included. Knockout achieved by CRISPR/Cas9; X = 1 bp insertion; Frameshift: 100%.

View Alternative Names

85 kDa lysosomal membrane sialoglycoprotein, 85 kDa lysosomal sialoglycoprotein scavenger receptor class B member 2, AMRF, CD36 antigen, CD36 antigen (collagen type I receptor, thrombospondin receptor)-like 2 (lysosomal integral membrane protein II), CD36 antigen-like 2, CD36L2, EPM4, HLGP85, LGP85, LIMP 2, LIMP II, Lysosomal integral membrane protein II, Lysosome membrane protein 2, Lysosome membrane protein II, OTTHUMP00000160590, OTTHUMP00000219176, SCRB2_HUMAN, SR BII, Scarb2, Scavenger receptor class B member 2

3 Images
Western blot - Human SCARB2 knockout MCF7 cell lysate (AB275010)
  • WB

Lab

Western blot - Human SCARB2 knockout MCF7 cell lysate (AB275010)

Lane 1 : Wild-type MCF7 cell lysate 20 μg
Lane 2 : SCARB2 knockout MCF7 cell lysate 20 μg
False colour image of Western blot : Anti-Scavenging Receptor SRB2 antibody [EPR12081] - C-terminal staining at 1/20000 dilution, shown in green; Mouse anti-GAPDH antibody [6C5] (ab8245) loading control staining at 1/20000 dilution, shown in red. In Western blot, ab196651 was shown to bind specifically to Scavenging Receptor SRB2. A band was observed at 80 kDa in wild-type MCF7 cell lysates with no signal observed at this size in SCARB2 knockout cell line ab274952 (knockout cell lysate ab275010). To generate this image, wild-type and SCARB2 knockout MCF7 cell lysates were analysed. First, samples were run on an SDS-PAGE gel then transferred onto a nitrocellulose membrane. Membranes were blocked in 3 % milk in TBS-0.1 % Tween® 20 (TBS-T) before incubation with primary antibodies overnight at 4 °C. Blots were washed four times in TBS-T, incubated with secondary antibodies for 1 h at room temperature, washed again four times then imaged. Secondary antibodies used were Goat anti-Rabbit IgG H&L (IRDye® 800CW) preabsorbed (ab216773) and Goat anti-Mouse IgG H&L (IRDye® 680RD) preabsorbed (ab216776) at 1/20000 dilution.

All lanes:

Western blot - Anti-Scavenging Receptor SRB2 antibody [EPR12081] - C-terminal (<a href='/en-us/products/primary-antibodies/scavenging-receptor-srb2-antibody-epr12081-c-terminal-ab196651'>ab196651</a>) at 1/20000 dilution

Lane 1:

Wild-type MCF7 cell lysate at 20 µg

Lane 2:

SCARB2 knockout MCF7 cell lysate at 20 µg

Lane 2:

Western blot - Human SCARB2 knockout MCF7 cell line (<a href='/en-us/products/cell-lines/human-scarb2-knockout-mcf7-cell-line-ab274952'>ab274952</a>)

Predicted band size: 54 kDa

Observed band size: 80 kDa

false

Western blot - Human SCARB2 knockout MCF7 cell lysate (AB275010)
  • WB

Lab

Western blot - Human SCARB2 knockout MCF7 cell lysate (AB275010)

Lane 1 : Wild-type MCF7 cell lysate 20 μg
Lane 2 : SCARB2 knockout MCF7 cell lysate 20 μg
Lane 3 : SH-SY5Y cell lysate 20 μg
Lane 4 : HEK-293 cell lysate 20 μg
False colour image of Western blot : Anti-LIMPII antibody [EPR12080] staining at 1/1000 dilution, shown in green; Mouse anti-GAPDH antibody [6C5] (ab8245) loading control staining at 1/20000 dilution, shown in red. In Western blot, ab176317 was shown to bind specifically to LIMPII. A band was observed at 80 kDa in wild-type MCF7 cell lysates with no signal observed at this size in SCARB2 knockout cell line ab274952 (knockout cell lysate ab275010). To generate this image, wild-type and SCARB2 knockout MCF7 cell lysates were analysed. First, samples were run on an SDS-PAGE gel then transferred onto a nitrocellulose membrane. Membranes were blocked in 3 % milk in TBS-0.1 % Tween® 20 (TBS-T) before incubation with primary antibodies overnight at 4 °C. Blots were washed four times in TBS-T, incubated with secondary antibodies for 1 h at room temperature, washed again four times then imaged. Secondary antibodies used were Goat anti-Rabbit IgG H&L (IRDye® 800CW) preabsorbed (ab216773) and Goat anti-Mouse IgG H&L (IRDye® 680RD) preabsorbed (ab216776) at 1/20000 dilution.

All lanes:

Western blot - Anti-LIMPII antibody [EPR12080] (<a href='/en-us/products/primary-antibodies/limpii-antibody-epr12080-ab176317'>ab176317</a>) at 1/1000 dilution

Lane 1:

Wild-type MCF7 cell lysate at 20 µg

Lane 2:

SCARB2 knockout MCF7 cell lysate at 20 µg

Lane 2:

Western blot - Human SCARB2 knockout MCF7 cell line (<a href='/en-us/products/cell-lines/human-scarb2-knockout-mcf7-cell-line-ab274952'>ab274952</a>)

Lane 3:

SH-SY5Y cell lysate at 20 µg

Lane 4:

HEK-293 cell lysate at 20 µg

Predicted band size: 54 kDa

Observed band size: 80 kDa

false

Next Generation Sequencing - Human SCARB2 knockout MCF7 cell lysate (AB275010)
  • NGS

Supplier Data

Next Generation Sequencing - Human SCARB2 knockout MCF7 cell lysate (AB275010)

Knockout achieved by CRISPR/Cas9; X = 1 bp insertion; Frameshift : 100%

Key facts

Cell type

MCF7

Species or organism

Human

Tissue

Breast

Knockout validation

Next Generation Sequencing,Western blot

Mutation description

Knockout achieved by CRISPR/Cas9; X = 1 bp insertion; Frameshift: 100%

Disease

Adenocarcinoma

Reactivity data

{ "title": "Reactivity Data", "filters": { "stats": ["", "Reactivity", "Dilution Info", "Notes"] }, "values": { "WB": { "reactivity":"TESTED_AND_REACTS", "dilution-info":"", "notes":"<p></p>" } } }

Product details

Knockout cell lysate achieved by CRISPR/Cas9.

REACH authorisation
Abcam has not and does not intend to apply for the REACH Authorisation of customers' uses of products that contain European Authorisation list (Annex XIV) substances.
It is the responsibility of our customers to check the necessity of application of REACH Authorisation, and any other relevant authorisations, for their intended uses.

Lysate preparation: Our lysates are made using RIPA buffer to which we add a protease inhibitor cocktail and phosphatase inhibitor cocktail (ratio: 300:100:10). This means that the protein of interest is denatured. If you require a native form of the protein please use the live cell version. Please refer to our lysis protocol for further details on how our lysates are prepared.

User storage instructions: Lyophilizate may be stored at 4°C. After reconstitution, store at -20°C for short-term storage or -80°C for long-term storage.

This product is subject to limited use licenses from The Broad Institute, ERS Genomics Limited and Sigma-Aldrich Co. LLC, and is developed with patented technology. For full details of the licenses and patents please refer to our limited use license and patent pages.

What's included?

{ "values": { "1Kit": { "sellingSize": "1 Kit", "publicAssetCode":"ab275010-1Kit", "assetComponentDetails": [ { "size":"1 x 100 µg", "name":"Human SCARB2 knockout MCF7 cell lysate", "number":"AB275010-CMP01", "productcode":"" }, { "size":"1 x 100 µg", "name":"Human wild-type MCF7 cell lysate", "number":"AB275010-CMP02", "productcode":"" } ] } } }

Properties and storage information

Gene name
SCARB2
Gene editing type
Knockout
Gene editing method
CRISPR technology
Knockout validation
Next Generation Sequencing, Western blot
Shipped at conditions
Ambient - Can Ship with Ice
Appropriate short-term storage conditions
-20°C
Appropriate long-term storage conditions
-20°C

Supplementary information

This supplementary information is collated from multiple sources and compiled automatically.

LIMPII also known as LIMP-2 is a lysosomal membrane protein involved in the transport and degradation processes within cells. It has an approximate molecular mass of 54 kDa. LIMPII is mainly expressed in the lysosomal membranes of a variety of tissues notably in the kidney liver and spleen. Its structural characteristics enable it to function effectively within these cellular organelles delivering enzymes and other molecules essential for cellular maintenance and function.
Biological function summary

The protein plays a critical role in lipid and protein degradation and helps maintain cellular homeostasis. As part of the lysosomal membrane LIMPII facilitates the uptake and processing of large biomolecules into the lysosome. It functions as a receptor for the uptake of β-glucocerebrosidase forming a complex to assist in its proper delivery from the endoplasmic reticulum to the lysosomes. This receptor-ligand relationship ensures efficient enzymatic activity necessary for lipid metabolism.

Pathways

One finds that LIMPII participates in the sphingolipid metabolism pathway and is vital for glucosylceramide catabolism. It interacts with glucocerebrosidase in this pathway which plays a significant role in the metabolism of glycosphingolipids. Another pathway where LIMPII has importance is the autophagy pathway where it contributes to the fusion of autophagosomes with lysosomes. Its activity supports the turnover of cellular components maintaining cellular metabolic balance.

LIMPII's dysfunction has links to Gaucher's disease and atherosclerosis. Both conditions relate to improper lipid metabolism. In Gaucher's disease the interaction between LIMPII and glucocerebrosidase becomes disrupted leading to lysosomal storage issues. In contrast altered expressions of LIMPII correlate with atherosclerosis possibly due to its role in lipid processing. These associations suggest that LIMPII could be a significant factor in therapeutic approaches for these diseases.

Cell culture

Biosafety level

EU: 1 US: 1

Adherent/suspension

Adherent

Gender

Female

Product protocols

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com